EUVIMEDEUVIMED entdecken
Crossref

Fatal cholestatic jaundice associated with amitriptyline

No author provided

University of Warwick · 10.09.2026

DOI: 10.82444/warw.33523162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift University of Warwick, erschienen am 10.09.2026. Verfasst von No author provided.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 75-year-old woman was admitted with a two-week history of anorexia and vague abdominal pain. She had been taking amitriptyline 75 mg at night for depression for four months before her admission. On presentation she was jaundiced, but with no stigmata of chronic liver disease. Initial liver function tests showed a slightly raised bilirubin, but were otherwise normal. Over the next three weeks her bilirubin concentration continued to rise without evidence of biliary obstruction on ultrasound examination. Her condition continued to deteriorate, and she later developed renal failure consistent with hepatorenal syndrome. Seven weeks after admission she died following a large gastrointestinal bleed. At autopsy, liver histology confirmed pure cholestasis consistent with amitriptyline ingestion.

Schlagwörter

amitriptylinedrug-induced liver injuryhepatorenal syndromerenal failuregastrointestinal bleedingdepressionadverse drug reactionselderly patients

Zitieren

APA

provided, N. A. (2026). Fatal cholestatic jaundice associated with amitriptyline. University of Warwick. https://doi.org/10.82444/warw.33523162

Vancouver

provided NA. Fatal cholestatic jaundice associated with amitriptyline. University of Warwick. 2026. doi:10.82444/warw.33523162

BibTeX
@article{provided2026,
  author = {provided, No author},
  title = {Fatal cholestatic jaundice associated with amitriptyline},
  journal = {University of Warwick},
  year = {2026},
  doi = {10.82444/warw.33523162}
}
Kostenlos starten →